CIS IS A POTENT CHECKPOINT IN NK CELL ANTI-LEUKEMIA IMMUNITY

被引：0
|
作者：
Huntington, N. [1 ]
机构：
[1] Walter & Eliza Hall, Mol Immunol, Parkville, Vic, Australia
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S815
引用
收藏
页码：335 / 336
页数：2
相关论文
共 50 条
  • [41] Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression
    Huang, Fang
    Wan, Jiangbo
    Hu, Weiwei
    Hao, Siguo
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 44 (01) : 240 - 254
  • [42] Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity
    Zhao, Chenchen
    Jia, Bei
    Jiang, Yixing
    Shike, Hiroko
    Annageldiyev, Charyguly
    Cioccio, Joseph
    Minagawa, Kentaro
    Mineishi, Shin
    Ehmann, Wchristopher
    Schell, Todd D.
    Cheng, Hua
    Zheng, Hong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (04)
  • [43] A novel class of piperidones exhibit potent, selective and pro-apoptotic anti-leukemia properties
    Nunes, Larissa M.
    Hossain, Mohammad
    Varela-Ramirez, Armando
    Das, Umashankar
    Ayala-Marin, Yoshira M.
    Dimmock, Jonathan R.
    Aguilera, Renato J.
    ONCOLOGY LETTERS, 2016, 11 (06) : 3842 - 3848
  • [44] Synthesis and biological evaluation of novel aromatic-heterocyclic biphenyls as potent anti-leukemia agents
    Dong, Jinyun
    Pan, Xiaoyan
    Wang, Jinfeng
    Su, Ping
    Zhang, Lin
    Wei, Fen
    Zhang, Jie
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 101 : 780 - 789
  • [45] Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy
    Kosugi, H
    Towatari, M
    Hatano, S
    Kitamura, K
    Kiyoi, H
    Kinoshita, T
    Tanimoto, M
    Murate, T
    Kawashima, K
    Saito, H
    Naoe, T
    LEUKEMIA, 1999, 13 (09) : 1316 - 1324
  • [46] Induction of anti-leukemia cell immunity by heat shock protein preparations after syngeneic bone marrow transplantation in mice.
    Sato, K
    Torimoto, Y
    Tamura, Y
    Iuchi, Y
    Shindo, M
    Shinzaki, H
    Kohgo, Y
    BLOOD, 2000, 96 (11) : 617A - +
  • [47] Erythrocyte-Based Biomimetic MOFs as a Triple Epigenetic Regulator for Enhancing Anti-Leukemia Immunity
    Ding, Min
    Dai, Xinlun
    Yang, Chunfeng
    Zhang, Zhen
    Wang, Zhihua
    Wang, Yiqiao
    Li, Yumei
    Yan, Fei
    Nano Letters, 2024, 24 (50) : 15989 - 15999
  • [48] Selective expansion of NK receptor-positive anti-leukemia cytotoxic T cells from leukemia patients treated with hematopoietic stem cell transplantation.
    Ogasawara, M
    Ogawa, T
    Imai, K
    Kobayashi, N
    Kiyama, Y
    Higa, T
    Tanaka, J
    Imamura, M
    Kasai, M
    BLOOD, 2002, 100 (11) : 57B - 57B
  • [49] Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy
    H Kosugi
    M Towatari
    S Hatano
    K Kitamura
    H Kiyoi
    T Kinoshita
    M Tanimoto
    T Murate
    K Kawashima
    H Saito
    T Naoe
    Leukemia, 1999, 13 : 1316 - 1324
  • [50] Homeostatic proliferation of leukemia specific cytotoxic T lymphocytes elicits effective anti-leukemia immunity in a mouse model.
    Wang, JM
    Lou, JW
    Zhang, WP
    Yang, JM
    Cao, YB
    Zhou, H
    BLOOD, 2003, 102 (11) : 257B - 257B
12345